 |
|
|
|
|
|
 Title: |
WO9403209A1:
DEXIBUPROFEN/ANTACID/SIMETHICONE COMBINATIONS[French]
[ Derwent Title ]
|
Country:
Kind: |
WO World Intellectual Property Organization (WIPO)
A1 INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT i
|
| |
| Inventor: |
SIMS, Robert, T.;
SLIVKA, William;
GATES, Thomas, N.;
|
| Assignee: |
MERCK & CO., INC.
MCNEIL-PPC, INC.
SIMS, Robert, T.
SLIVKA, William
GATES, Thomas, N.
News, Profiles, Stocks and More about this company
|
| Published / Filed: |
1994-02-17
/ 1993-07-19
|
| Application Number: |
WO1993US0006725
|
| IPC Code: |
Advanced:
A61K 33/00;
A61K 33/08;
A61K 33/10;
A61K 33/12;
IPC-7:
A61K 33/08;
A61K 45/06;
|
| ECLA Code: |
A61K33/08; A61K33/00; A61K33/10; A61K33/12;
|
| Priority Number: |
| 1992-07-29 |
US1992000921880 |
|
| Abstract: |
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and in the relief of indigestion, sour stomach, heartburn und other gastrointestinal disorders in mammals, including humans, by administering compositions comprising (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprofen wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen-(R)-lysine; and (ii) an amount effective in the treatment of acid indigestion, sour stomach, heartburn, and other gastrointestinal disorders of an antacid; and (iii) simethicone.
[French]
|
| INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report
|
| Designated Country: |
AT AU BB BE BF BG BJ BR CA CF CG CH CI CM CZ DE DK ES FI FR GA GB GN GR HU IE IT JP KR KZ LK LU MC MG ML MN MR MW NE NL NO NZ PL PT RO RU SD SE SK SN TD TG UA US
|
| Family: |
Show 3 known family members
|
First Claim:
Show all claims |
1.A pharmaceutical composition for use in the treatment of pain and inflammation and the treatment of gastrointestinal disorders such as indigestion, sour stomach and heartburn in mammals, including humans comprising: (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprof6n wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen-(R)-lysine; and (ii) an amount effective in the treatment of indigestion, sour stomach, heartburn, and other gastrointestinal disorders of at least one antacid; and (iii) an amount effective in the treatment of flatulence of simethicone.
|
Description
Expand description |
+ TITLE
OF'THE INVENTIO DEXIBUPROFEN/ANTACID/SIMETHICONE COMBINATIONS
+ BACKGROUND
|
